{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:41Z","timestamp":1786985621891,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.canrad.2021.11.020","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T09:47:54Z","timestamp":1640252874000},"page":"397-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Radiation therapy of cutaneous cancers"],"prefix":"10.1016","volume":"26","author":[{"given":"C.","family":"Hennequin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Qu\u00e9ro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Clav\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.11.020_bib0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.prro.2019.10.014","article-title":"Definitive and postoperative radiation therapy for basal and squamous cell cancers of the skin: executive summary of an American Society for Radiation Oncology Clinical Practice Guideline","volume":"10","author":"Likhacheva","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0275","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0360-3016(94)00603-I","article-title":"Electron beam therapy is not inferior to superficial x-ray therapy in the treatment of skin carcinoma","volume":"32","author":"Griep","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.020_bib0280","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2018.01.013","article-title":"GEC-ESTRO ACROP recommendations in skin brachytherapy","volume":"126","author":"Guinot","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0285","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/M18-0678","article-title":"Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta-analysis","volume":"169","author":"Drucker","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.canrad.2021.11.020_bib0290","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jaad.2012.06.001","article-title":"Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients","volume":"67","author":"Cognetta","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0295","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2005.07.045","article-title":"Soft x-ray therapy for cutaneous basal cell and squamous cell carcinomas","volume":"53","author":"Schulte","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0300","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","article-title":"Inhibition of the hedgehog pathway in advanced basal-cell carcinoma","volume":"361","author":"Von Hoff","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2021.11.020_bib0305","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jamadermatol.2015.0326","article-title":"Concurrent vismodegib and radiotherapy for recurrent, advanced basal cell carcinoma","volume":"151","author":"Pollom","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0310","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2020.01.008","article-title":"European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment","volume":"128","author":"Stratigos","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2021.11.020_bib0315","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0320","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamaoto.2018.4515","article-title":"Outcomes of cutaneous squamous cell carcinoma in the head and neck region with regional lymph node metastasis: a systematic review and meta-analysis","volume":"145","author":"Sahovaler","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.canrad.2021.11.020_bib0325","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2017.77.0941","article-title":"Postoperative concurrent chemoradiotherapy versus postoperative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck: the randomized phase III TROG 05.01 trial","volume":"36","author":"Porceddu","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0330","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.oraloncology.2018.01.015","article-title":"Combination of postoperative radiotherapy and cetuximab for high-risk cutaneous squamous cell cancer of the head and neck: a propensity score analysis","volume":"78","author":"Palmer","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0335","doi-asserted-by":"crossref","first-page":"f6153","DOI":"10.1136\/bmj.f6153","article-title":"Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies","volume":"347","author":"Lansbury","year":"2013","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.canrad.2021.11.020_bib0340","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3109\/09546634.2012.751481","article-title":"Efficacy of cetuximab in the treatment of squamous cell carcinoma","volume":"25","author":"Preneau","year":"2014","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.canrad.2021.11.020_bib0345","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.radonc.2010.02.024","article-title":"Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases","volume":"95","author":"van Hezewijk","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0350","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2017.08.011","article-title":"Hypofractionated radiation therapy for basal and squamous cell skin cancer: a meta-analysis","volume":"125","author":"Zaorsky","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0355","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13014-020-01615-2","article-title":"Radiotherapy for lentigo maligna and lentigo maligna melanoma\u00a0\u2013\u00a0a systematic review","volume":"15","author":"Hendrickx","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0360","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bjd.12611","article-title":"Radiotherapy for lentigo maligna: a literature review and recommendations for treatment","volume":"170","author":"Fogarty","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0365","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/jdv.13252","article-title":"A systematic review of non-surgical treatments for lentigo maligna","volume":"30","author":"Read","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0370","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/cncr.28412","article-title":"Radiotherapy influences local control in patients with desmoplastic melanoma","volume":"120","author":"Strom","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2021.11.020_bib0375","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/hed.2880170303","article-title":"Mucosal melanoma of the nasal cavity and paranasal sinuses","volume":"17","author":"Kingdom","year":"1995","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2021.11.020_bib0380","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/archotol.129.8.864","article-title":"The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region","volume":"129","author":"Owens","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.canrad.2021.11.020_bib0385","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2002.03.002","article-title":"Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma","volume":"20","author":"Ballo","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0390","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1245\/s10434-018-7072-7","article-title":"Completion lymph node dissection or radiation therapy for sentinel node metastasis in Merkel cell carcinoma","volume":"26","author":"Lee","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0395","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1002\/cncr.24627","article-title":"The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma","volume":"115","author":"Agrawal","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2021.11.020_bib0400","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1470-2045(12)70138-9","article-title":"Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial","volume":"13","author":"Burmeister","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0405","doi-asserted-by":"crossref","first-page":"102032","DOI":"10.1016\/j.ctrv.2020.102032","article-title":"Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: a systematic review","volume":"87","author":"Baetz","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canrad.2021.11.020_bib0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2019.07.001","article-title":"Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial","volume":"119","author":"Eggermont","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2021.11.020_bib0415","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/02656739609023685","article-title":"Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology","volume":"12","author":"Overgaard","year":"1996","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.canrad.2021.11.020_bib0420","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0360-3016(99)00131-5","article-title":"Nodal radiation therapy for metastatic melanoma","volume":"44","author":"Corry","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.020_bib0425","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0167-8140(89)90017-0","article-title":"Clinical radiobiology of malignant melanoma","volume":"16","author":"Bentzen","year":"1989","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0430","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/0360-3016(85)90042-2","article-title":"A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma","volume":"11","author":"Overgaard","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.020_bib0435","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(06)70758-6","article-title":"Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma","volume":"7","author":"Stevens","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0440","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/bjd.14240","article-title":"Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases","volume":"174","author":"Gunaratne","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0445","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s10434-001-0204-4","article-title":"Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases","volume":"8","author":"Medina-Franco","year":"2001","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.canrad.2021.11.020_bib0450","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw042","article-title":"Adjuvant radiation therapy and chemotherapy in merkel cell carcinoma: survival analyses of 6908 cases from the National Cancer data base","volume":"108","author":"Bhatia","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2021.11.020_bib0455","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1200\/JCO.2006.07.9319","article-title":"Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin","volume":"25","author":"Mojica","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0460","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2019.02.015","article-title":"Adjuvant radiotherapy for Merkel cell carcinoma: a systematic review and meta-analysis","volume":"134","author":"Petrelli","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0465","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/annonc\/mdr318","article-title":"Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study","volume":"23","author":"Jouary","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0470","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.ejca.2015.06.131","article-title":"Diagnosis and treatment of Merkel cell carcinoma. European consensus-based interdisciplinary guideline","volume":"51","author":"Lebbe","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2021.11.020_bib0475","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amjsurg.2017.10.045","article-title":"Surgical resection improves median overall survival with marginal improvement in long-term survival when compared with definitive radiotherapy in Merkel cell carcinoma: a propensity score matched analysis of the National Cancer Database","volume":"215","author":"Wright","year":"2018","journal-title":"Am J Surg"},{"key":"10.1016\/j.canrad.2021.11.020_bib0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2017.02.015","article-title":"Definitive radiotherapy for Merkel cell carcinoma confers clinically meaningful in-field locoregional control: a review and analysis of the literature","volume":"77","author":"Gunaratne","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0485","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2009.05.067","article-title":"Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin","volume":"77","author":"Foote","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.020_bib0490","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamadermatol.2017.2176","article-title":"Identifying an optimal adjuvant radiotherapy dose for extremity and trunk Merkel cell carcinoma following resection: an analysis of the National Cancer database","volume":"153","author":"Patel","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0495","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jaad.2012.04.018","article-title":"Treatments for classic Kaposi sarcoma: a systematic review of the literature","volume":"68","author":"Regnier-Rosencher","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0500","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1468-3083.2007.02405.x","article-title":"Radiotherapy of classic and human immunodeficiency virus-related Kaposi's sarcoma: results in 1482 lesions","volume":"22","author":"Caccialanza","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2013.08.033","article-title":"Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part II. Prognosis, management, and future directions","volume":"70","author":"Jawed","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0510","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","article-title":"Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Specht","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.020_bib0515","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaad.2014.10.014","article-title":"Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials","volume":"72","author":"Hoppe","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.canrad.2021.11.020_bib0520","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.06.1918","article-title":"Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas","volume":"74","author":"Neelis","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2021.11.020_bib0525","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2021.11.020_bib0530","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821003103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321821003103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:35:55Z","timestamp":1761136555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321821003103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":53,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1278321821003103"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.11.020","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation therapy of cutaneous cancers","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}